Table 3.
Univarate associations between clinical characteristics, microorganisms and outcomes
| NIV | IMV | P | Death | P | ||
|---|---|---|---|---|---|---|
| Male | 1.1 [0.8–1.6] | 0.5 | 1.9 [1.2–3.0] | 0.009 | 1.2 [0.8–1.8] | 0.4 |
| Age | 1.0 [1.0–1.0] | 0.07 | 0.96 [0.95–0.97] | < 0.001 | 1.01 [1.0–1.03] | 0.05 |
| Diabetes | 1.4 [1.0–2.1] | 0.09 | 1.5 [0.9–2.4] | 0.1 | 1.2 [0.74–1.9] | 0.5 |
| CKD | 1.3 [0.8–2.1] | 0.2 | 1.2 [0.7–2.2] | 0.6 | 1.4 [0.8–2.3] | 0.2 |
| HF | 1.2 [0.8–1.8] | 0.3 | 0.6 [0.3–1.0] | 0.05 | 1.0 [0.6–1.5] | 1.0 |
| CLD | 0.8 [0.3–2.4] | 0.8 | 0.7 [0.2–2.9] | 0.6 | 0.3 [0.0–1.9] | 0.2 |
| COPD/Asthma | 2.3 [1.6–3.4] | < 0.001 | 1.1 [0.7–1.9] | 0.6 | 1.1 [0.7–1.7] | 0.8 |
| ILD | 2.3 [0.7–7.5] | 0.2 | 2.8 [0.8–10.1] | 0.1 | 1.3 [0.3–5.9] | 0.7 |
| OSA/OHS | 7.2 [4.0–13.0] | < 0.001 | 2.3 [1.0–5.0] | 0.04 | 2.0 [1.0–4.3] | 0.07 |
| Solid organ transplant | 1.4 [0.5–4.3] | 0.5 | [0.8–7.6] | 0.1 | 0.9 [0.2–2.7] | 0.8 |
| Solid neoplasm | 0.9 [0.4–1.9] | 0.7 | 0.6 [0.2–1.9] | 0.4 | 2.3 [1.2–4.6] | 0.01 |
| Hematological neoplasm | 0.6 [0.3–1.2] | 0.2 | 1.0 [0.5–2.1] | 0.9 | 1.4 [0.8–2.4] | 0.3 |
| HIV | 1.6 [0.5–4.6] | 0.5 | – | – | 0.4 [0.1–3.2] | 0.4 |
| Influneza A | 1.0 [0.7–1.4] | 0.9 | 1.4 [0.9–2.3] | 0.1 | 0.9 [0.6–1.4] | 0.8 |
| H1N1 | 2.6 [1.7–4.0] | < 0.001 | 6.0 [3.7–9.7] | < 0.001 | 1.8 [1.1–3.0] | 0.02 |
| H3N2 | 0.4 [0.3–0.7] | 0.001 | 0.2 [0.1–0.5] | < 0.001 | 0.6 [0.4–1.1] | 0.08 |
| Influenza B | 0.7 [0.4–1.1] | 0.1 | 09 [0.5–1.6] | 0.7 | 0.9 [0.6–1.5] | 0.8 |
| RSV | 1.5 [1.0–2.2] | 0.08 | 0.6 [0.3–1.2] | 0.1 | 1.2 [0.7–1.9] | 0.5 |
Bold values indicate statistically significant P values (P < 0.05)